why choose us

First received: May 25, 2023

Clinical Trial: Precision Cancer Therapy in Rare Cancers

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Rare Malignant Neoplasm

Study Type: INTERVENTIONAL


Official Title: The MATRIX Clinical Studies of Precision Cancer Therapy for Rare Cancers

Brief Summary: Some rare cancers are hard-to-treat and patients have a poor prognosis.It is known that some of these patients have targetable molecular alterations, and some benefit from targeted drugs.However in many cases these drugs are not approved for the rare cancers.In this study the aim is to do advanced molecular diagnostics to identify possible targets for therapy, and to treat accordingly.

Read more